# An Independent Reading Room, Not a Storefront

> About Avant Peptides — Avant Peptides is an independent, cited research digest covering five peptides at different points on the translational gap — not a clinic, not a pharmacy, not a source.

**ABOUT**

Why this site exists, how it decides what to write, and what it deliberately does not do.

## Why this site exists

Search results for these peptides are crowded with pages promising instructions, sources, and fast outcomes. Much harder to find is a page that simply says what the published research found — and is equally clear about what it did not find.

Avant Peptides was built to be that second kind of page. Research claims trace back to a specific study, trial, or regulatory document, listed in full on the [references](/references) page and cited by number in the text. Where the evidence is strong, we say so. Where it consists mainly of rodent work plus a tiny human safety pilot, we say that too [17][18].

## The organizing idea: the translational gap

Every compound here started as a laboratory hypothesis. What separates them is how far each has traveled since — the scale of human testing, whether it earned regulatory approval, and the exact condition covered by that approval. We call that distance the *translational gap*. It is the single lens this site uses across every page: not "is this peptide good or bad," but "how much evidence exists, and for which claim?"

That framing matters because the gap can disappear behind the phrase "studies show." Such a phrase might describe a cardiovascular outcomes trial with 17,604 participants [3] or a safety pilot with two participants [17]. Both statements can look equally confident on a page while resting on very different foundations. Avant Peptides names the study type, population, and scale whenever those details matter.

## How we handle community reports

Alongside the published clinical literature, some of these compounds — particularly BPC-157 and PT-141 — have active online communities reporting personal experiences. Those reports show what people notice and discuss, and we include them where relevant, but label them clearly as **anecdotal, not clinical evidence**. We never attach a specific dose to a community report. A recurring self-reported pattern can help frame a question; it is still not the same thing as a controlled trial, and this site does not conflate the two.

## What this site is not

Avant Peptides is not a clinic, pharmacy, or vendor. It sells nothing, prescribes nothing, and recommends no dose to any reader. Nothing here is medical advice or a substitute for care from a qualified clinician. Where a compound is an approved prescription medicine, the site says so and marks the scope of that approval; where a compound remains an unapproved research chemical, the site says that plainly as well.

The goal is narrow and specific: to provide an honest account of how far the evidence reaches for each compound before stronger claims are accepted. It is a reading room for comparing evidence, not a service for making personal treatment decisions.

---

Avant Peptides independently maps the distance from peptide benchwork to approved medicine; it is an editorial digest, not a clinic, pharmacy, or prescription.